Praluenthcp.com

Visit praluenthcp.com
  • 11 months ago

    Last scanned

  • 8 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Praluenthcp.com

Visit praluenthcp.com

Overal rating:

B9876A78-C14B-4F49-9F4B-396039336A47@1x

About Website

Updated:

Medication to Reduce Cardiovascular Risk | PRALUENT® (alirocumab) Injection

Learn about PRALUENT, a PCSK9 inhibitor, that is approved to help reduce the risk of certain CV events in adults with established cardiovascular disease. Get access to ODYSSEY OUTCOMES trial data and read Important Safety Information on website.

99E6BC28-40D1-4264-B66E-CBC423C983BF@1x

Network Data

This website is hosted with Intouch Group, LLC, which reserves the following IP addresses for praluenthcp.com: 192.103.124.92. Moreover, DNS used with this website include ns1.markmonitor.com, ns2.markmonitor.com, ns3.markmonitor.com, ns4.markmonitor.com, ns5.markmonitor.com, ns6.markmonitor.com, ns7.markmonitor.com. Subnet identifier ranges from 192.103.124.0 to 192.103.125.255. Classless Inter-Domain Routing (CIDR) is 192.103.124.0/23. ARIN net type is Direct Allocation.

  • 11 months ago

    Last scanned

  • 8 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Network

ADDRESSING DETAILS

  • Hosting Company

    Intouch Group, LLC

  • IPs

    192.103.124.92

  • DNS

    ns1.markmonitor.com

    ns2.markmonitor.com

    ns3.markmonitor.com

    ns4.markmonitor.com

    ns5.markmonitor.com

    ns6.markmonitor.com

    ns7.markmonitor.com

Whois

OWNERSHIP

Domain & Keywords

The registrar of praluenthcp.com is MarkMonitor Inc. and the name expires on 2024-06-04. According to open source data, you can reach the owner at domains@regeneron.com but please make sure you have a good reason for unsolicited messages. Their country of residence is United States of America.

  • alirocumab
  • praluent
  • list reports
  • praluent copay card
  • praluent pen

Websites similar to praluenthcp.com

Praluenthcp.com friends